세계의 코로나 바이러스 백신용 바이알 시장예측 2021년-2026년

■ 영문 제목 : Global Vials for COVID-19 Vaccine Market Growth 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2107K00998 입니다.■ 상품코드 : LPI-2107K00998
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 6월
■ 페이지수 : 130
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 포장
■ 판매가격 / 옵션 (부가세별도)
Single User (1명 열람용)USD3,660 ⇒환산₩4,026,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산₩6,039,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산₩8,052,000견적의뢰/구입/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
본 조사보고서는 코로나 바이러스 백신용 바이알의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (중간산 붕규산염 유리, 저탄산 붕규산염 유리)와 용도별 시장규모 (백신 제조, 백신 연구) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 코로나 바이러스 백신용 바이알 시장 점유율
- 지역별 코로나 바이러스 백신용 바이알 시장규모
- 주요지역의 종류별 시장규모 (중간산 붕규산염 유리, 저탄산 붕규산염 유리)
- 주요지역의 용도별 시장규모 (백신 제조, 백신 연구)
- 미주의 코로나 바이러스 백신용 바이알 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 코로나 바이러스 백신용 바이알 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 코로나 바이러스 백신용 바이알 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 코로나 바이러스 백신용 바이알 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 코로나 바이러스 백신용 바이알 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Vials for COVID-19 Vaccine will have significant change from previous year. By the most conservative estimates of global Vials for COVID-19 Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vials for COVID-19 Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vials for COVID-19 Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Middle-borate Borosilicate Glass
Low-borate Borosilicate Glass

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Vaccine Manufacturing
Vaccine Researching

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Corning
Schott AG
SiO2 Materials Science
SGD Pharma
Stevanato Group
DWK Life Sciences
Gerresheimer

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vials for COVID-19 Vaccine Consumption 2016-2026
2.1.2 Vials for COVID-19 Vaccine Consumption CAGR by Region
2.2 Vials for COVID-19 Vaccine Segment by Type
2.2.1 Middle-borate Borosilicate Glass
2.2.2 Low-borate Borosilicate Glass
2.3 Vials for COVID-19 Vaccine Sales by Type
2.3.1 Global Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Vials for COVID-19 Vaccine Sale Price by Type (2016-2021)
2.4 Vials for COVID-19 Vaccine Segment by Application
2.4.1 Vaccine Manufacturing
2.4.2 Vaccine Researching
2.5 Vials for COVID-19 Vaccine Sales by Application
2.5.1 Global Vials for COVID-19 Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Vials for COVID-19 Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Vials for COVID-19 Vaccine Sale Price by Application (2016-2021)

3 Global Vials for COVID-19 Vaccine by Company
3.1 Global Vials for COVID-19 Vaccine Sales Market Share by Company
3.1.1 Global Vials for COVID-19 Vaccine Sales by Company (2019-2021)
3.1.2 Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Company
3.2.1 Global Vials for COVID-19 Vaccine Revenue by Company (2019-2021)
3.2.2 Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Vials for COVID-19 Vaccine Sale Price by Company
3.4 Global Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vials for COVID-19 Vaccine Product Location Distribution
3.4.2 Players Vials for COVID-19 Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Vials for COVID-19 Vaccine by Region
4.1 Global Vials for COVID-19 Vaccine by Region
4.1.1 Global Vials for COVID-19 Vaccine Sales by Region
4.1.2 Global Vials for COVID-19 Vaccine Revenue by Region
4.2 Americas Vials for COVID-19 Vaccine Sales Growth
4.3 APAC Vials for COVID-19 Vaccine Sales Growth
4.4 Europe Vials for COVID-19 Vaccine Sales Growth
4.5 Middle East & Africa Vials for COVID-19 Vaccine Sales Growth

5 Americas
5.1 Americas Vials for COVID-19 Vaccine Sales by Country
5.1.1 Americas Vials for COVID-19 Vaccine Sales by Country (2016-2021)
5.1.2 Americas Vials for COVID-19 Vaccine Revenue by Country (2016-2021)
5.2 Americas Vials for COVID-19 Vaccine Sales by Type
5.3 Americas Vials for COVID-19 Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Vials for COVID-19 Vaccine Sales by Region
6.1.1 APAC Vials for COVID-19 Vaccine Sales by Region (2016-2021)
6.1.2 APAC Vials for COVID-19 Vaccine Revenue by Region (2016-2021)
6.2 APAC Vials for COVID-19 Vaccine Sales by Type
6.3 APAC Vials for COVID-19 Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Vials for COVID-19 Vaccine by Country
7.1.1 Europe Vials for COVID-19 Vaccine Sales by Country (2016-2021)
7.1.2 Europe Vials for COVID-19 Vaccine Revenue by Country (2016-2021)
7.2 Europe Vials for COVID-19 Vaccine Sales by Type
7.3 Europe Vials for COVID-19 Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Vials for COVID-19 Vaccine by Country
8.1.1 Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Vials for COVID-19 Vaccine Sales by Type
8.3 Middle East & Africa Vials for COVID-19 Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vials for COVID-19 Vaccine Distributors
10.3 Vials for COVID-19 Vaccine Customer

11 Global Vials for COVID-19 Vaccine Market Forecast
11.1 Global Vials for COVID-19 Vaccine Forecast by Region
11.1.1 Global Vials for COVID-19 Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Vials for COVID-19 Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Vials for COVID-19 Vaccine Forecast by Type
11.7 Global Vials for COVID-19 Vaccine Forecast by Application

12 Key Players Analysis
12.1 Corning
12.1.1 Corning Company Information
12.1.2 Corning Vials for COVID-19 Vaccine Product Offered
12.1.3 Corning Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Corning Main Business Overview
12.1.5 Corning Latest Developments
12.2 Schott AG
12.2.1 Schott AG Company Information
12.2.2 Schott AG Vials for COVID-19 Vaccine Product Offered
12.2.3 Schott AG Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Schott AG Main Business Overview
12.2.5 Schott AG Latest Developments
12.3 SiO2 Materials Science
12.3.1 SiO2 Materials Science Company Information
12.3.2 SiO2 Materials Science Vials for COVID-19 Vaccine Product Offered
12.3.3 SiO2 Materials Science Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 SiO2 Materials Science Main Business Overview
12.3.5 SiO2 Materials Science Latest Developments
12.4 SGD Pharma
12.4.1 SGD Pharma Company Information
12.4.2 SGD Pharma Vials for COVID-19 Vaccine Product Offered
12.4.3 SGD Pharma Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 SGD Pharma Main Business Overview
12.4.5 SGD Pharma Latest Developments
12.5 Stevanato Group
12.5.1 Stevanato Group Company Information
12.5.2 Stevanato Group Vials for COVID-19 Vaccine Product Offered
12.5.3 Stevanato Group Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Stevanato Group Main Business Overview
12.5.5 Stevanato Group Latest Developments
12.6 DWK Life Sciences
12.6.1 DWK Life Sciences Company Information
12.6.2 DWK Life Sciences Vials for COVID-19 Vaccine Product Offered
12.6.3 DWK Life Sciences Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 DWK Life Sciences Main Business Overview
12.6.5 DWK Life Sciences Latest Developments
12.7 Gerresheimer
12.7.1 Gerresheimer Company Information
12.7.2 Gerresheimer Vials for COVID-19 Vaccine Product Offered
12.7.3 Gerresheimer Vials for COVID-19 Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Gerresheimer Main Business Overview
12.7.5 Gerresheimer Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Vials for COVID-19 Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Middle-borate Borosilicate Glass
Table 3. Major Players of Low-borate Borosilicate Glass
Table 4. Global Vials for COVID-19 Vaccine Sales by Type (2016-2021) & (Million Units)
Table 5. Global Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global Vials for COVID-19 Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global Vials for COVID-19 Vaccine Sale Price by Type (2016-2021)
Table 9. Global Vials for COVID-19 Vaccine Sales by Application (2016-2021) & (Million Units)
Table 10. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global Vials for COVID-19 Vaccine Value by Application (2016-2021)
Table 12. Global Vials for COVID-19 Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global Vials for COVID-19 Vaccine Sale Price by Application (2016-2021)
Table 14. Global Vials for COVID-19 Vaccine Sales by Company (2019-2021) & (Million Units)
Table 15. Global Vials for COVID-19 Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global Vials for COVID-19 Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Vials for COVID-19 Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global Vials for COVID-19 Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Vials for COVID-19 Vaccine Producing Area Distribution and Sales Area
Table 20. Players Vials for COVID-19 Vaccine Products Offered
Table 21. Vials for COVID-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vials for COVID-19 Vaccine Sales by Region (2016-2021) (Million Units)
Table 25. Global Vials for COVID-19 Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global Vials for COVID-19 Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Vials for COVID-19 Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas Vials for COVID-19 Vaccine Sales by Country (2016-2021) & (Million Units)
Table 29. Americas Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas Vials for COVID-19 Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas Vials for COVID-19 Vaccine Sales by Type (2016-2021) & (Million Units)
Table 33. Americas Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas Vials for COVID-19 Vaccine Sales by Application (2016-2021) & (Million Units)
Table 35. Americas Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC Vials for COVID-19 Vaccine Sales by Region (2016-2021) & (Million Units)
Table 37. APAC Vials for COVID-19 Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC Vials for COVID-19 Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Vials for COVID-19 Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC Vials for COVID-19 Vaccine Sales by Type (2016-2021) & (Million Units)
Table 41. APAC Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC Vials for COVID-19 Vaccine Sales by Application (2016-2021) & (Million Units)
Table 43. APAC Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe Vials for COVID-19 Vaccine Sales by Country (2016-2021) & (Million Units)
Table 45. Europe Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe Vials for COVID-19 Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe Vials for COVID-19 Vaccine Sales by Type (2016-2021) & (Million Units)
Table 49. Europe Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe Vials for COVID-19 Vaccine Sales by Application (2016-2021) & (Million Units)
Table 51. Europe Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Vials for COVID-19 Vaccine Sales by Country (2016-2021) & (Million Units)
Table 53. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Vials for COVID-19 Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Vials for COVID-19 Vaccine Sales by Type (2016-2021) & (Million Units)
Table 57. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Vials for COVID-19 Vaccine Sales by Application (2016-2021) & (Million Units)
Table 59. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Vials for COVID-19 Vaccine
Table 61. Key Application and Potential Industries of Vials for COVID-19 Vaccine
Table 62. Key Challenges of Vials for COVID-19 Vaccine
Table 63. Key Trends of Vials for COVID-19 Vaccine
Table 64. Vials for COVID-19 Vaccine Distributors List
Table 65. Vials for COVID-19 Vaccine Customer List
Table 66. Global Vials for COVID-19 Vaccine Sales Forecast by Region (2021-2026) & (Million Units)
Table 67. Global Vials for COVID-19 Vaccine Consumption Market Forecast by Region
Table 68. Global Vials for COVID-19 Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Vials for COVID-19 Vaccine Sales Forecast by Country (2021-2026) & (Million Units)
Table 71. Americas Vials for COVID-19 Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Vials for COVID-19 Vaccine Sales Forecast by Region (2021-2026) & (Million Units)
Table 73. APAC Vials for COVID-19 Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Vials for COVID-19 Vaccine Sales Forecast by Country (2021-2026) & (Million Units)
Table 75. Europe Vials for COVID-19 Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Vials for COVID-19 Vaccine Sales Forecast by Country (2021-2026) & (Million Units)
Table 77. Middle East & Africa Vials for COVID-19 Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Vials for COVID-19 Vaccine Sales Forecast by Type (2021-2026) & (Million Units)
Table 79. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Vials for COVID-19 Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Vials for COVID-19 Vaccine Sales Forecast by Application (2021-2026) & (Million Units)
Table 83. Global Vials for COVID-19 Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Vials for COVID-19 Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Vials for COVID-19 Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 86. Corning Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Corning Vials for COVID-19 Vaccine Product Offered
Table 88. Corning Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 89. Corning Main Business
Table 90. Corning Latest Developments
Table 91. Schott AG Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Schott AG Vials for COVID-19 Vaccine Product Offered
Table 93. Schott AG Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 94. Schott AG Main Business
Table 95. Schott AG Latest Developments
Table 96. SiO2 Materials Science Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. SiO2 Materials Science Vials for COVID-19 Vaccine Product Offered
Table 98. SiO2 Materials Science Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 99. SiO2 Materials Science Main Business
Table 100. SiO2 Materials Science Latest Developments
Table 101. SGD Pharma Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. SGD Pharma Vials for COVID-19 Vaccine Product Offered
Table 103. SGD Pharma Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 104. SGD Pharma Main Business
Table 105. SGD Pharma Latest Developments
Table 106. Stevanato Group Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Stevanato Group Vials for COVID-19 Vaccine Product Offered
Table 108. Stevanato Group Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 109. Stevanato Group Main Business
Table 110. Stevanato Group Latest Developments
Table 111. DWK Life Sciences Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. DWK Life Sciences Vials for COVID-19 Vaccine Product Offered
Table 113. DWK Life Sciences Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 114. DWK Life Sciences Main Business
Table 115. DWK Life Sciences Latest Developments
Table 116. Gerresheimer Basic Information, Vials for COVID-19 Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 117. Gerresheimer Vials for COVID-19 Vaccine Product Offered
Table 118. Gerresheimer Vials for COVID-19 Vaccine Sales (Million Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2019-2021E)
Table 119. Gerresheimer Main Business
Table 120. Gerresheimer Latest Developments
List of Figures
Figure 1. Picture of Vials for COVID-19 Vaccine
Figure 2. Vials for COVID-19 Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vials for COVID-19 Vaccine Sales Growth Rate 2016-2026 (Million Units)
Figure 7. Global Vials for COVID-19 Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Vials for COVID-19 Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Middle-borate Borosilicate Glass
Figure 10. Product Picture of Low-borate Borosilicate Glass
Figure 11. Global Vials for COVID-19 Vaccine Sales Market Share by Type in 2020
Figure 12. Global Vials for COVID-19 Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. Vials for COVID-19 Vaccine Consumed in Vaccine Manufacturing
Figure 14. Global Vials for COVID-19 Vaccine Market: Vaccine Manufacturing (2016-2021) & (Million Units)
Figure 15. Vials for COVID-19 Vaccine Consumed in Vaccine Researching
Figure 16. Global Vials for COVID-19 Vaccine Market: Vaccine Researching (2016-2021) & (Million Units)
Figure 17. Global Vials for COVID-19 Vaccine Sales Market Share by Application (2016-2021)
Figure 18. Global Vials for COVID-19 Vaccine Revenue Market Share by Application in 2020
Figure 19. Vials for COVID-19 Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Vials for COVID-19 Vaccine Revenue Market Share by Company in 2020
Figure 21. Global Vials for COVID-19 Vaccine Sales Market Share by Regions (2016-2021)
Figure 22. Global Vials for COVID-19 Vaccine Revenue Market Share by Region in 2020
Figure 23. Americas Vials for COVID-19 Vaccine Sales 2016-2021 (Million Units)
Figure 24. Americas Vials for COVID-19 Vaccine Revenue 2016-2021 ($ Millions)
Figure 25. APAC Vials for COVID-19 Vaccine Sales 2016-2021 (Million Units)
Figure 26. APAC Vials for COVID-19 Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. Europe Vials for COVID-19 Vaccine Sales 2016-2021 (Million Units)
Figure 28. Europe Vials for COVID-19 Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Vials for COVID-19 Vaccine Sales 2016-2021 (Million Units)
Figure 30. Middle East & Africa Vials for COVID-19 Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Americas Vials for COVID-19 Vaccine Sales Market Share by Country in 2020
Figure 32. Americas Vials for COVID-19 Vaccine Revenue Market Share by Country in 2020
Figure 33. Americas Vials for COVID-19 Vaccine Sales Market Share by Type in 2020
Figure 34. Americas Vials for COVID-19 Vaccine Sales Market Share by Application in 2020
Figure 35. United States Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Vials for COVID-19 Vaccine Sales Market Share by Region in 2020
Figure 40. APAC Vials for COVID-19 Vaccine Revenue Market Share by Regions in 2020
Figure 41. APAC Vials for COVID-19 Vaccine Sales Market Share by Type in 2020
Figure 42. APAC Vials for COVID-19 Vaccine Sales Market Share by Application in 2020
Figure 43. China Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Vials for COVID-19 Vaccine Sales Market Share by Country in 2020
Figure 50. Europe Vials for COVID-19 Vaccine Revenue Market Share by Country in 2020
Figure 51. Europe Vials for COVID-19 Vaccine Sales Market Share by Type in 2020
Figure 52. Europe Vials for COVID-19 Vaccine Sales Market Share by Application in 2020
Figure 53. Germany Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Vials for COVID-19 Vaccine Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Vials for COVID-19 Vaccine Sales Market Share by Application in 2020
Figure 62. Egypt Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Vials for COVID-19 Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
※본 조사보고서 [세계의 코로나 바이러스 백신용 바이알 시장예측 2021년-2026년] (코드 : LPI-2107K00998) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 코로나 바이러스 백신용 바이알 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.